Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Partial Epilepsy”

544 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 544 results

Large-scale testing (Phase 3)Study completedNCT00988429
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 653
Not applicableLooking for participantsNCT07013331
What this trial is testing

A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome

Who this might be right for
EpilepsyDravet SyndromeDrug Resistant Epilepsy+1 more
Hospices Civils de Lyon 30
Testing effectiveness (Phase 2)Study completedNCT00236873
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Not applicableUnknownNCT05951244
What this trial is testing

Cathodal Transcranial Direct Current Stimulation in Patients With Drug-resistant Focal Epilepsy

Who this might be right for
Drug Resistant Epilepsy
Koç University 40
Large-scale testing (Phase 3)Study completedNCT00744731
What this trial is testing

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial, MotorEpilepsy, Complex PartialEpilepsy, Simple Partial+1 more
SK Life Science, Inc. 403
Testing effectiveness (Phase 2)Study completedNCT00416195
What this trial is testing

Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Co., Ltd. 48
Post-approval studies (Phase 4)WithdrawnNCT02220972
What this trial is testing

To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures

Who this might be right for
Epilepsy, Partial
Eisai Inc.
Not applicableStudy completedNCT02262156
What this trial is testing

CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients

Who this might be right for
DepressionEpilepsy, Temporal Lobe
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez 15
Post-approval studies (Phase 4)Study completedNCT00630357
What this trial is testing

Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy

Who this might be right for
Epilepsy
UCB Pharma 14
Post-approval studies (Phase 4)Study completedNCT05419180
What this trial is testing

Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies

Who this might be right for
Pharmacoresistant Focal Epilepsies
Biocodex 52
Not applicableUnknownNCT02804230
What this trial is testing

MR-Guided Focused Ultrasound in the Treatment of Focal Epilepsy (EP001)

Who this might be right for
Epilepsy
InSightec 20
Post-approval studies (Phase 4)Study completedNCT00659958
What this trial is testing

ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs

Who this might be right for
Epilepsy
Eisai Inc. 32
Testing effectiveness (Phase 2)WithdrawnNCT00567424
What this trial is testing

GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Who this might be right for
Epilepsy
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT01142193
What this trial is testing

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Who this might be right for
Epilepsy
Upsher-Smith Laboratories 249
Testing effectiveness (Phase 2)Study completedNCT00938431
What this trial is testing

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Who this might be right for
Epilepsy
UCB Pharma 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT04015141
What this trial is testing

Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy

Who this might be right for
Pediatric Epileptic SyndromePartial-onset Seizures
Eisai Inc. 100
Not applicableUnknownNCT05248269
What this trial is testing

Thermocoagulation in Drug Resistant Focal Epilepsy

Who this might be right for
EpilepsySeizures, FocalEpilepsy Intractable+1 more
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia 75
Not applicableStudy completedNCT01858870
What this trial is testing

Observational Retrospective Study of Effectivity and Tolerability in Patients With Lacosamide Medication

Who this might be right for
Epilepsy
Instituto de Investigacion Sanitaria La Fe 860
Testing effectiveness (Phase 2)Study completedNCT03754582
What this trial is testing

Intravenous Perampanel in Japanese Participants With Epilepsy

Who this might be right for
EpilepsySeizures
Eisai Co., Ltd. 21
Early research (Phase 1)Study completedNCT00426673
What this trial is testing

An Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15 Adult Patients With Epilepsy.

Who this might be right for
Epilepsy
UCB Pharma 15
Next Page